A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

Our results offer 'proof of concept' for the future use of a pharmaceutical senolytic strategy to reduce the risk of ...

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled "Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer ...

Uganda has treated its first patient using advanced stem cell therapy, marking a ground-breaking milestone in East Africa's medical history.Stem cell therapy, also known as regenerative medicine, uses ...

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her resignation from employment of the ...

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.